GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmesis International Ltd (SGX:BFK) » Definitions » Net Margin %

Pharmesis International (SGX:BFK) Net Margin % : -21.84% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Pharmesis International Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Pharmesis International's Net Income for the six months ended in Dec. 2023 was S$-0.73 Mil. Pharmesis International's Revenue for the six months ended in Dec. 2023 was S$3.35 Mil. Therefore, Pharmesis International's net margin for the quarter that ended in Dec. 2023 was -21.84%.

The historical rank and industry rank for Pharmesis International's Net Margin % or its related term are showing as below:

SGX:BFK' s Net Margin % Range Over the Past 10 Years
Min: -47.51   Med: -6.5   Max: 3.93
Current: -10.84


SGX:BFK's Net Margin % is ranked worse than
68.76% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 3.255 vs SGX:BFK: -10.84

Pharmesis International Net Margin % Historical Data

The historical data trend for Pharmesis International's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmesis International Net Margin % Chart

Pharmesis International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -47.51 -12.37 2.21 -7.07 -10.86

Pharmesis International Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.31 -16.26 -1.62 -3.76 -21.84

Competitive Comparison of Pharmesis International's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmesis International's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmesis International's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmesis International's Net Margin % distribution charts can be found below:

* The bar in red indicates where Pharmesis International's Net Margin % falls into.



Pharmesis International Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Pharmesis International's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.925/8.514
=-10.86 %

Pharmesis International's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.731/3.347
=-21.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmesis International  (SGX:BFK) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Pharmesis International Net Margin % Related Terms

Thank you for viewing the detailed overview of Pharmesis International's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmesis International (SGX:BFK) Business Description

Traded in Other Exchanges
N/A
Address
5 Kallang Sector, No. 03-02, Singapore, SGP, 349279
Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its geographical segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution. The company derives revenue from the sale of medicines to domestic customers in China.

Pharmesis International (SGX:BFK) Headlines